GLP-1 price war heats up as Novo Nordisk offers $199 starter doses
The company is lowering costs on its blockbuster drugs to fend off competitors, compounding pharmacies, and mounting political pressure.
Novo Nordisk, the Danish drug company that makes Ozempic and Wegovy, is now offering the drugs at lower prices for self-pay patients.
What did you think of this news? Leave a comment below and/or share it on your social media. This way, we can inform more people about the hottest things in technology, science, innovation, and gaming!
This news was originally published in:
Original source
